Regulatory T-cell immunity and its relevance to atherosclerosis

Journal of Internal Medicine

Volumn 263, Issue 5, 2008, Pages 489-499

  Taleb, S ^a   Tedgui, A ^a   Mallat, Z ^a  

^a INSERM   (France)

Author keywords

Atherosclerosis; Cytokines; Immunity; Inflammation; Lymphocytes

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; CONFERENCE PAPER; DISEASE COURSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ATHEROSCLEROSIS; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY, NATURAL; INTERLEUKIN-10; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 42149195139     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01944.x     Document Type: Conference Paper

References (93)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 : 1685 95.
2. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006 86 : 515 81.
3. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007 7 : 875 88.
4. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 : 508 19.
5. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 32.
6. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005 6 : 1133 41.
7. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 8.
8. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 : 179 89.
9. Zhou L, Ivanov II., Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007 8 : 967 74.
10. Nurieva R, Yang XO, Martinez G et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007 448 : 480 3.
11. Korn T, Bettelli E, Gao W et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007 448 : 484 7.
12. Song L, Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 2004 177 : 43 51.
13. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999 19 : 2364 7.
14. Ait-Oufella H, Salomon BL, Potteaux S et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 12 : 178 80.
15. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell immunity in atherosclerosis. Trends Cardiovasc Med 2007 17 : 113 8.
16. + regulatory T cells: selfishness under scrutiny. Immunity 2007 27 : 417 9.
17. + regulatory T cells in the steady state. J Exp Med 2003 198 : 737 46.
18. + T cells in the periphery. Nat Rev Immunol 2007 7 : 231 7.
19. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005 22 : 329 41.
20. + regulatory T cells. Nat Immunol 2003 4 : 330 6.
21. Lin W, Haribhai D, Relland LM et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007 8 : 359 68.
22. Wu Y, Borde M, Heissmeyer V et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006 126 : 375 87.
23. Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007 446 : 685 9.
24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
25. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007 8 : 277 84.
26. Marson A, Kretschmer K, Frampton GM et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007 445 : 931 5.
27. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007 445 : 936 40.
28. Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004 101 : 10398 403.
29. Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003 4 : 1206 12.
30. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4(+)CD25(+) Foxp3(+) regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4(+) T cells. Nat Immunol 2007 8 : 1353 62.
31. Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 : 566 9.
32. Kulkarni AB, Karlsson S. Transforming growth factor-beta-1 knockout mice - a mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993 143 : 3 9.
33. Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992 359 : 693 9.
34. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006 25 : 455 71.
35. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006 25 : 441 54.
36. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004 172 : 6003 10.
37. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001 194 : 629 44.
38. Piccirillo CA, Letterio JJ, Thornton AM et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002 196 : 237 46.
39. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007 26 : 579 91.
40. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005 35 : 2886 95.
41. Fahlen L, Read S, Gorelik L et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 2005 201 : 737 46.
42. + regulatory T cell activity in both humans and mice. J Immunol 2004 172 : 834 42.
43. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007 178 : 179 85.
44. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005 115 : 1923 33.
45. Apostolou I, Von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004 199 : 1401 8.
46. Mucida D, Park Y, Kim G et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007 317 : 256 60.
47. Sun CM, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007 204 : 1775 85.
48. Lacy-Hulbert A, Smith AM, Tissire H et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc Natl Acad Sci U S A 2007 104 : 15823 8.
49. Travis MA, Reizis B, Melton AC et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007 449 : 361 5.
50. McGeachy MJ, Bak-Jensen KS, Chen Y et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007 8 : 1390 7.
51. Mallat Z, Gojova A, Marchiol-Fournigault C et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001 89 : 930 4.
52. Lutgens E, Gijbels M, Smook M et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 2002 22 : 975 82.
53. Grainger DJ, Mosedale DE, Metcalfe JC, Bottinger EP. Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J Cell Sci 2000 113 : 2355 61.
54. Gojova A, Brun V, Esposito B et al. Specific abrogation of transforming growth factor-{beta} signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 2003 102 : 4052 8.
55. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003 112 : 1342 50.
56. + regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27 : 893 900.
57. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996 184 : 241 51.
58. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999 190 : 995 1004.
59. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 : 737 42.
60. + regulatory T cells. J Immunol 2004 172 : 5986 93.
61. + Tr cells. Blood 2005 105 : 1162 9.
62. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003 18 : 605 17.
63. - precursor cells in the absence of interleukin 10. Nat Immunol 2007 8 : 931 41.
64. Stumhofer JS, Silver JS, Laurence A et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007 8 : 1363 71.
65. Mallat Z, Besnard S, Duriez M et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999 85 : e17 24.
66. Pinderski Oslund LJ, Hedrick CC, Olvera T et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999 19 : 2847 53.
67. Caligiuri G, Rudling M, Ollivier V et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003 9 : 10 7.
68. Potteaux S, Esposito B, Van Oostrom O et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2004 24 : 1474 8.
69. -/- mice. FASEB J 2001 15 : 2730 2.
70. Pinderski LJ, Fischbein MP, Subbanagounder G et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002 90 : 1064 71.
71. Hagenbaugh A, Sharma S, Dubinett SM et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med 1997 185 : 2101 10.
72. Mallat Z, Gojova A, Brun V et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108 : 1232 7.
73. Ait-Oufella H, Horvat B, Kerdiles Y et al. Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice. Circulation 2007 116 : 1707 13.
74. Gotsman I, Grabie N, Gupta R et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006 114 : 2047 55.
75. Heller EA, Liu E, Tager AM et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 2006 113 : 2301 12.
76. Mor A, Luboshits G, Planer D, Keren G, George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006 27 : 2530 7.
77. De Boer OJ, Van der Meer JJ, Teeling P, Van der Loos CM, Van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2007 2 : e779.
78. + Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 2007 124 : 90 7.
79. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003 9 : 1202 8.
80. Steffens S, Burger F, Pelli G et al. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 2006 114 : 1977 84.
81. Van Puijvelde GH, Hauer AD, De Vos P et al. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 2006 114 : 1968 76.
82. Van Puijvelde GH, Van Es T, Van Wanrooij EJ et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27 : 2677 83.
83. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998 394 : 897 901.
84. Siegmund B, Sennello JA, Jones-Carson J et al. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 2004 53 : 965 72.
85. Matarese G, Di Giacomo A, Sanna V et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001 166 : 5909 16.
86. De Rosa V, Procaccini C, La Cava A et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest 2006 116 : 447 55.
87. Lee CH, Chen YG, Chen J et al. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis. Diabetes 2006 55 : 171 8.
88. Taleb S, Herbin O, Ait-Oufella H et al. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27 : 2691 8.
89. De Rosa V, Procaccini C, Cali G et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007 26 : 241 55.
90. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 2002 40 : 1333 8.
91. Maron R, Sukhova G, Faria AM et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002 106 : 1708 15.
92. Lemarie CA, Esposito B, Tedgui A, Lehoux S. Pressure-induced vascular activation of nuclear factor-kappaB: role in cell survival. Circ Res 2003 93 : 207 12.
93. Ait-Oufella H, Kinugawa K, Zoll J et al. Lactadherin-deficiency induces apoptotic cell accumulation, alters the regulatory immune response, and accelerates atherosclerosis in mice. Circulation 2007 115 : 2168 77.